Search Results - Hasvold, L.P.

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    PDB118 OUTCOMES AND HEALTHCARE COSTS FOR PATIENTS WITH TYPE 2 DIABETES UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION IN SWEDEN: A NATIONWIDE OBSERVATIONAL STUDY

    PDB118 OUTCOMES AND HEALTHCARE COSTS FOR PATIENTS WITH TYPE 2 DIABETES UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION IN SWEDEN: A NATIONWIDE OBSERVATIONAL STUDY by Norhammar, A., Erlinge, D., Hasvold, L.P., Bodegård, J., Kritikou, P., Mellstrom, C., Jernberg, T., Janzon, M.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PRS4 SABA OVERUSE AND HEALTH CARE RESOURCE UTILIZATION IN A NATIONWIDE SWEDISH ASTHMA COHORT (HERA)

    PRS4 SABA OVERUSE AND HEALTH CARE RESOURCE UTILIZATION IN A NATIONWIDE SWEDISH ASTHMA COHORT (HERA) by Janson, C., Nwaru, B., Hasvold, L.P., Wicklund, F., Telg, G., Ekström, M.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    2260Different cardiovascular outcomes in patients with myocardial infarction and peripheral arterial disease - Swedish nationwide data

    2260Different cardiovascular outcomes in patients with myocardial infarction and peripheral arterial disease - Swedish nationwide data by Sigvant, B., Jernberg, T., Hasvold, L.P., Thuresson, M., Johansson, S., Nordanstig, J., Janzon, M.

    Published in European heart journal
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients

    Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients by Hasvold, Lars Pål, Bodegard, Johan, Thuresson, Marcus, Stålhammar, J, Hammar, N, Sundstrom, J, Russell, David, Kjeldsen, Sverre Erik

    Request full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    PCV88 PHARMACY COLLECTION OF PRESCRIBED SECONDARY PREVENTIVE DRUG THERAPY AFTER MYOCARDIAL INFARCTION - A NORWEGIAN NATIONWIDE COHORT STUDY

    PCV88 PHARMACY COLLECTION OF PRESCRIBED SECONDARY PREVENTIVE DRUG THERAPY AFTER MYOCARDIAL INFARCTION - A NORWEGIAN NATIONWIDE COHORT STUDY by Jortveit, J., Thuresson, M., Hasvold, L.P., Halvorsen, S.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: